628 results on '"Barbacid,, M."'
Search Results
2. The RAF/MEK clamp VS-6766 shows strong anti-tumor activity across multiple MAPK pathway alterations, with a preferential effect on KRAS G12V
3. Structure of the RAF1-HSP90-CDC37 complex (RHC-I)
4. Ras signaling is essential for skin development
5. Deciphering the RAS/MAPKinase signaling pathway in cancer
6. P52.05 Dual RAF/MEK Inhibitor VS-6766 for Treatment of KRAS Mutant NSCLC: Novel Combinations Targeting G12C or G12V Variants
7. Upregulation of miR-21 by Ras in vivo and its role in tumor growth
8. Cyclin-dependent kinase 2 is dispensable for normal centrosome duplication but required for oncogene-induced centrosome overduplication
9. Pancreatic islets from cyclin-dependent kinase 4/R24C (Cdk4) knockin mice have significantly increased beta cell mass and are physiologically functional, indicating that Cdk4 is a potential target for pancreatic beta cell mass regeneration in Type 1 diabetes
10. TARGETING RAS ONCOGENE SIGNALING IN CANCER: GENETIC AND PHARMACOLOGICAL APPROACHES: 018
11. Expression of Kras and its effectors determines resistance to oncogenic Kras
12. Evaluation of fluorometric and zymographic methods as activity assays for stromelysins and gelatinases
13. Need for global action for cancer control
14. Genetic analysis of the mammalian cell cycle: Cdk1 is sufficient to drive mammalian cell division: C2-L4
15. Differential dependency of unmyelinated and Adelta epidermal and upper dermal innervation on neurotrophins, trk receptors, and p77(super LNGFR)
16. Oncogenic CDK4 Mutation Promotes Rapid Growth of Invasive Metastatic Melanoma in Carcinogen-Treated HGF/SF-Transgenic Mice
17. Differential dependency of cutaneous mechanoreceptors on neurotrophins, trk receptors, and P75 LNGFR
18. 52 (PB042) - The RAF/MEK clamp VS-6766 shows strong anti-tumor activity across multiple MAPK pathway alterations, with a preferential effect on KRAS G12V
19. Genetic analysis of cell cycle cyclin-dependent kinases: SL11-063
20. ERRATUM
21. On the right TRK: from oncogene discovery to cancer therapeutics
22. Evaluation of fluorometric and zymographic methods as activity assays for stromelysins and gelatinases
23. Effects of gamma-linolenic acid and oleic acid on paclitaxel cytotoxicity in human breast cancer cells
24. trkA modulation of developing somatosensory neurons in oro-facial tissues: tooth pulp fibers are absent in trkA knockout mice
25. PO-211 KRAS driven lung adenocarcinoma depends on ERBB signalling
26. Molecular Assays for Detection of ras Oncogenes in Human and Animal Tumors
27. Genetic Approaches Toward Elucidating the Mechanisms of Type-C Virus-Induced Leukemia
28. Antibiotic Action on the Ribosomal Peptidyl Transferase Centre
29. Early Detection of ras Oncogenes Activated by Chemical Carcinogentreatment
30. Lkb1 loss promotes tumor progression of BRAF(V600E)-induced lung adenomas
31. Effects of gamma-linolenic acid and oleic acid on paclitaxel cytotoxicity in human breast cancer cells
32. Mouse models of cancer
33. Ras in epidermal proliferation
34. Genetically engineered mouse models of pancreatic adenocarcinoma
35. Concurrent deletion of cyclin E1 and cyclin-dependent kinase 2 in hepatocytes inhibits DNA replication and liver regeneration in mice
36. miR-21 deregulation in thyroid cancer
37. In vivo oncogenic conflict triggered by co-existing KRAS and EGFR activating mutations in lung adenocarcinoma
38. Dissecting the roles of Fra proteins in lung adenocarcinoma
39. Myc-dependent cell cycle progression through the activation of CDK1 and phosphorylation of p27
40. The European dimension for the mouse genome mutagenesis program
41. Activation of a type C virus particle in cells from the inbred mouse strain 129/J: Antigenic relationship with the horizontally transmitted type C viruses of primates
42. INACTIVATION OF CYCLIN E1 ACTS PRO-APOPTOTIC AND ANTI-PROLIFERATIVE IN PRIMARY HEPATOMA CELLS AND PROTECTS FROM HEPATOCARCINOGENESIS IN MICE
43. P0285 : Inactivation of cyclin E1 acts pro-apoptotic and anti-proliferative in primary hepatoma cells and protects from hepatocarcinogenesis in mice
44. Genetic Approaches Toward Elucidating the Mechanisms of Type-C Virus-Induced Leukemia
45. Antibiotic Action on the Ribosomal Peptidyl Transferase Centre
46. Inactivation of Cyclin E1 acts pro-apoptotic and anti-proliferative in primary hepatoma cells and protects from hepatocarcinogenesis in mice
47. Nicotine triggers initiation and progression of K-Ras driven pancreatic ductal adenocarcinoma via acinar cell de-differentiation
48. 191: Heterogeneity among early-stage K-Ras driven lung adenocarcinoma predicts tumor aggressiveness and identifies Ddr1 as a therapeutic target
49. 304: Myc mediates the phosphorylation and degradation of p27 through activation of Cyclin A/CDK1
50. Reply: ‘Comments on Stromal disrupting effects of nab-paclitaxel in pancreatic cancer’
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.